Hematopoietic growth factors in neonatal medicine: the use of enterally administered hematopoietic growth factors in the neonatal intensive care unit.
The practice of complete bowel rest in prematurely delivered neonates and those who have undergone surgery for congenital anomalies of the gastrointestinal (GI) tract is common in neonatal intensive care units (NICU). However, increased recognition of the critical role of growth factors in GI development suggests that this practice might be modified to include the administration of synthetic amniotic fluid-like solutions designed to bridge the neonate between their intra-uterine environment and that of the NICU. This article reviews advances in administering synthetic amniotic fluid-like solutions in the NICU.
Calhoun
Darlene A
DA
Department of Pediatrics, Division of Neonatology, University of South Florida College of Medicine and All Children's Hospital, Children's Research Institute, 140 7th Avenue South CRI 2006, St. Petersburg, FL 33701, USA. dcalhoun@hsc.usf.edu
Christensen
Robert D
RD
D000653:Amniotic Fluid / Q000737:chemistry; D000818:Animals; D005314:Embryonic and Fetal Development; D016298:Hematopoietic Cell Growth Factors / Q000008:administration & dosage*; D006801:Humans; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007422:Intestines / Q000196:embryology; D007441:Intubation, Gastrointestinal; D009359:Neonatology / Q000379:methods*; D012996:Solutions / Q000008:administration & dosage
D016298:Hematopoietic Cell Growth Factors; D012996:Solutions